Small benefits in trastuzumab-related cardiotoxicity
Small benefits in trastuzumab-related cardiotoxicity
About this item
Full title
Small benefits in trastuzumab-related cardiotoxicity
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
The lancet oncology, 2017-01, Vol.18 (1), p.e5-e5
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
According to previous studies, angiotensin-converting enzyme inhibitors and β blockers are established drugs for the initial management of cardiac failure and cancer treatment-associated cardiac dysfunction.
Alternative Titles
Full title
Small benefits in trastuzumab-related cardiotoxicity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1859474366
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1859474366
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(16)30639-8
